Cellular Therapy Laboratory Research
The following clinical studies have been possible at Mount Sinai because of the Stem Cell Laboratory’s active participation:
- Use of expanded cord products for transplantation
- Use of mesenchymal precursor cells on myocardial function in LVAD bridge to transplant patients
- Use of autologous CD34+ positive cells for improved symptomatic relief and ischemic wound healing in patients with critical limb ischemia
- Intravenous infusion of human placenta-derived cells for the treatment of adults with multiple sclerosis
- Intravenous infusion of human placenta-derived cells for the treatment of adults with Crohn’s disease
Investigators are encouraged to contact Ding Wen Wu, MD, PhD, Associate Director of Transfusion Medicine / Cellular Therapy, or Yelena Sinitsyn, Supervisor of the Cellular Therapy Lab, during the grant-writing process to seek advice on the most appropriate stem cell processing and storage protocols.